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Natural exposure to pollen reduces the threshold
but does not change the pattern of response to the
allergen in allergic subjects
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It is known that exposure to seasonal allergen in sensitized asthmatics increases non-specific bronchial
responsiveness, but it is controversial if exposure to seasonal allergen influences the presence and the severity of
the late asthmatic response (LAR) to allergen.
Fifteen asthmatic subjects sensitized to grass pollen performed a specific bronchial provocative test (sBPT) with
Phleum pratensis extract before and during the pollen season. Changes of methacholine were also assessed.
Allergen PD20FEV1 significantly decreased during the pollen season with respect to outside (allergen PD20FEV1,
geometric mean: 0?10 vs. 0?23 biological units; P50?05), but the pattern of specific airway response did not change.
Particularly, a consistent LAR was observed in three subjects outside the pollen season and in two subjects during
the pollen season. Seven subjects with isolated early asthmatic response (EAR) outside the season did not show
LAR after allergen inhalation during the pollen season. However, four of five subjects with slight LAR outside the
pollen season (DFEV1% between 15 and 20%) lost LAR during season. Methacholine sensitivity increased slightly
but significantly from outside to during the pollen season. This increase was greater in subjects with LAR outside
the pollen season.
The natural exposure to pollen induces an increase in bronchial sensitivity to allergen in sensitized subjects, but it
does not induce LAR in subjects without LAR outside the pollen season.
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The inhalation of allergen in the laboratory can induce a
specific airway reaction in sensitized subjects which can
result in an early (EAR) and/or a late airway response
(LAR) (1). EAR measures the sensitivity of airways to
allergen. Conclusive evidence indicates that the EAR is
determined by the level of allergic sensitivity and by the
level of non-specific airway responsiveness (as determined
by airway sensitivity to methacholine or histamine) (2,3).
The development of a subsequent LAR is associated with a
greater severity of the disease (4). Also, a transient
worsening of the severity of asthma, such as that induced
from viral infection of the respiratory tract, determines the
development of LAR after allergen challenge in subjects
with previous isolated EAR (5). Several studies had shown
that natural exposure to pollens induces an increase in non-
specific bronchial hyperresponsiveness to non-specificReceived 25 February 2000 and accepted in revised form 12 June
2000. Published online 12 September 2000.
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sensitized subjects. It could be expected that the sensitivity
of the airways to the inhalation of a specific allergen,
expressed as EAR, should be increased after natural
exposure to the allergen, but conflicting results have been
reported (9–11). To the best of our knowledge, only one
paper reported the changes in the degree of the LAR in
asthmatic subjects sensitized to the birch pollen at the end
of the seasonal exposure to the allergen (9).
The aim of this study was to verify whether the natural
exposure to the allergen was able to significantly change the
threshold and the pattern of airway response to the
inhalation of specific allergen in sensitized subjects. A
group of subjects sensitized to grass pollen (Phleum
pratensis) and with symptoms of asthma and rhinitis during
the period of natural seasonal exposure to a such allergen
was examined before and during the pollen season using a
similar schedule.
Methods
SUBJECTS
Fifteen subjects [nine male and six female subjects, mean
age: 23?7 years (range: 13,36)] with mild asthma during the# 2000 HARCOURT PUBLISHERS LTD
1074 F. L. DENTE ET AL.grass pollen season were selected on the basis of a positive
skin prick test to Graminaceae in the absence of skin
sensitivity to other allergens (namely Dermatophagoides,
Alternaria, Parietaria, Olea, and dog and cat danders).
Eleven subjects also reported seasonal rhinitis. All subjects
were examined in a stable phase of the disease, that is no
infections during the previous 4 weeks. Subjects were
examined in two different time periods: (i) outside the
pollen season (from September to March) in a symptom-
free period; (ii) during the grass pollen season (from May to
July) when they were symptomatic, mean 7 weeks (range 4–
10 weeks) after the beginning of the pollen season. During
the season, nine out of 15 subjects used regular therapy: six
used anti-histamines; five ketotifen; one cetirizine; one
sodium cromoglycate; two low-dose beclomethasone di-
propionate. The pollen season was confirmed by measure-
ments of the concentrations of grass pollen in the
atmosphere of three main towns in Tuscany during the
period of the study and expressed as total pollen counts per
m3 of air in 1 week. Usually, the concentration of grass
pollen significantly increased in the last week of April or in
the first week of May, and persisted until the second or
third week of July. Specific bronchial provocative tests
during the pollen season were executed in 2 consecutive
years after at least 4 and before 10 weeks from the
beginning of season to obtain a long exposition to pollen
with small inter-subject differences. The time-courses of
pollen seasons are represented in Fig. 1.
Outside the pollen season, all subjects showed a positive
skin prick test to grass pollen (mean wheal diameter,
7nagative control,  5mm), and a normal baseline FEV1
(except subject No. 11) (Table 1). Non-specific bronchial
hyperresponsiveness to methacholine was present in 11 of
15 subjects, but respiratory symptoms were absent outside
the pollen season.FIG 1. Time courses of pollens during 2 consecutive years in whic
duration of pollen season and the grey area represents time in wIn the two evaluations (outside and during the season)
the subjects performed, on different days and with informed
consent, non-specific bronchial challenge test with metha-
choline and specific bronchial provocative test (sBPT) with
allergen. Before each challenge test the pharmacological
treatment was withdrawn following the usual recommenda-
tions (12).
SPECIFIC BRONCHIAL PROVOCATIVE
TEST WITH ALLERGEN
The sBPT was performed with allergens standardized in
biological units (BU). Allergen extract solution was
delivered by a DeVilbiss 646 jet nebulizer (DeVilbiss Health
Care, Somerset, PA, U.S.A.) using a procedure previously
described (13). Lyophilized allergen extract (NeoAbello`,
Milano, Italy) was dissolved in saline in order to obtain two
working solutions with different concentrations (1 and
10BUml71). The nebulizer was filled with 3 ml of diluent
(phenol 0?4% in saline) or allergen solution; the nebulizer
was connected to a dosimeter (Passerini, Pontedera, Italy)
driven by compressed air and activated by the beginning of
inhalation. With the nebulizer vent closed, and a 20 psi inlet
pressure and 1 sec long nebulization, the output was
10+ 1ml, measured by weighing the nebulizer before and
after one discharge. The aerodynamic mass median
diameter of the aerosol generated was 1?2 mm (geometric
standard deviation, 2?9), measured with a cascade impac-
tor. The output of the nebulizer was regularly checked
every 3 months, and any change in the output was modified
to obtain the same output of the solution. Each subject
wore a nose clip and was instructed to breath via a
mouthpiece from functional residual capacity. The nebuli-
zer was filled with 3ml of allergen solution or diluenth the study was performed. The white square represents the
hich specific bronchial provocative tests were performed.
TABLE 1. Main clinical features of the examined subjects at the first evaluation outside the grass pollen season
No. Age
(years)
Sex Duration of
disease (years)
FEV1
(% predicted)
SPT
(mm)
Diagnosis
1 32 Female 30 111 8 Asthma
2 25 Male 4 117 11 Rhinitis and asthma
3 20 Male 18 97 10 Rhinitis and asthma
4 27 Male 27 107 13 Rhinitis and asthma
5 23 Female 17 122 10 Rhinitis and asthma
6 17 Male 10 110 9 Rhinitis and asthma
7 16 Male 5 111 5 Asthma
8 26 Male 17 108 10 Rhinitis and asthma
9 24 Female 2 94 8 Rhinitis and asthma
10 36 Female 20 88 6 Rhinitis and asthma
11 31 Female 6 70 7 Rhinitis and Asthma
12 13 Male 1 121 12 Rhinitis and Asthma
13 17 Male 3 110 8 Rhinitis and Asthma
14 26 Male 21 97 6 Asthma
15 22 Male 10 132 11 Asthma
SPT=skin prick test with mix Graminaceae (mean wheal diameter).
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baseline spirometry, the patient inhaled three puffs of
diluent, followed at 10 min intervals by incremental doses
of allergen to obtain a series of cumulative doses: 0?025,
0?05, 0?1, 0?2, 0?4, 0?8, 1?6, and 3?2 BU. FEV1 was
measured 10 min after the end of each series of allergen
inhalations by means of a Biomedin water sealed spirom-
eter connected to an Olivetti microcomputer. The inhala-
tions were continued until FEV1 fell more than 20% below
the post-diluent value or until the top concentration had
been administered, and the total dose (TD) of allergen
delivered into the airways was calculated. FEV1 was then
measured at 20, 30 and 60min, and then hourly for 7 h. A
fall in FEV1 greater than 20% between 10 and 60 min
was considered to be an EAR, and a fall of FEV1
greater than 15% between the third and the seventh hour
after the challenge was considered to be a LAR, respec-
tively. The dose of allergen causing a 20% fall in FEV1
from post-diluent value (PD20FEV1 allergen) was derived
from a log dose–response curve and was used to evaluate
the degree of EAR; the maximal percent FEV1 fall between
the third and the seventh hour was used to express the
degree of LAR.
The short-term and long-term reproducibility of EAR
and LAR had been previously assessed (14).
METHACHOLINE CHALLENGE TEST
Methacholine was delivered by a DeVilbiss 646 jet nebulizer
using the previously described procedure (13). Phosphate
buffered saline was inhaled first, followed every 2 min by
methacholine inhalation of cumulative doses of 0?04–
3?2mg FEV1 was measured until it fell more than 20%
below the post-diluent value and PD20FEV1 (the cumula-tive dose producing a 20% fall of FEV1) was computed. In
a previous study, the reproducibility of methacholine
PD20FEV1 was assessed: methacholine PD20FEV1 varied
 50% in nine of 12 subjects (variability, 27%).
STATISTICAL ANALYSIS
Arithmetic mean (M) and standard deviation (SD) were used
to evaluate DFEV1% fall during EAR and LAR. Geo-
metric mean (GM) expressed mean values of methacholine
and allergen PD20FEV1 and TD of delivered allergen
during specific bronchial challenges. Area under the curve
(AUC) of sBPT (between the second and the seventh hour
after allergen inhalation) was computed by the method of
trapezoidal integration. Statistical analysis was performed
using ANOVA and paired t-test; a level of probability
lower than 5% was considered significant (15). To use
statistical parametric methods, logarithmic transformation
of methacholine and allergen PD20FEV1 and TD of
delivered allergen was performed (16).
Results
Individual and mean values of the response to non-specific
and specific bronchial provocative test performed outside
and during grass pollen season are reported in Table 2.
Bronchial hyperreactivity to methacholine slightly, but
significantly, increased during the grass pollen season
[methacholine PD20FEV1, GM+ geometric SD: from 0?88
(0?11) to 0?50 (0?12), P=0?01]. Methacholine PD20FEV1
5 1mg was observed in nine of 15 subjects outside the
pollen season and in 11 of 15 subjects during the pollen
season. Six of 15 subjects showed a reduction of one
doubling dose of methacholine at least during pollen
TABLE 2. Bronchial responsiveness to methacholine (PD20FEV1) and to allergen (PD20 FEV1) in the evaluations performed
outside and during the pollen season
Methacholine PD20FEV1
(mg)
Allergen PD20FEV1
(BU)
EAR
(DFEV1% fall)
LAR
(DFEV1% fall)
AUC
# Out In Out In Out In Out In Out In
1 0?36 0?23 0?16 0?20 722 727 715 712 280 288
2 0?66 0?12 0?18 0?01 727 731 717 71 175 202
3 0?18 0?06 0?20 0?21 726 726 717 þ2 179 210
4 43?2 0?43 0?07 0?07 730 737 75 0 195 201
5 1?53 0?47 0?12 0?08 739 728 þ12 76 186 190
6 0?95 0?60 3?21 1?47 724 726 73 75 197 193
7 0?76 0?46 0?24 0?04 752 729 722 þ3 160 207
8 43?2 43?2 0?23 0?07 722 738 75 718 193 179
9 0?56 0?47 0?70 0?06 745 732 721 720 174 165
10 0?11 0?12 0?02 0?02 723 723 72 76 203 190
11 0?56 0?25 0?17 0?05 728 750 728 748 150 134
12 0?20 0?12 0?15 0?04 747 726 718 78 173 187
13 43?2 43?2 0?64 0?13 723 719 710 716 184 185
14 1?63 2?93 0?09 0?30 730 730 74 76 194 188
15 43?2 43?2 1?84 0?92 726 722 719 717 166 172
Mean 0?88{ * 0?05 0?23{ * 0?10{ 731 NS 730 713 NS 711 187 NS 193
SD 10 8 8 13 30 32
EAR: early asthmatic response; LAR: laate asthmatic response; AUC: area under curve.
(*P50?05 between outside and during the pollen season {Geometric mean).
1076 F. L. DENTE ET AL.season in comparison with the methacholine challenge
performed outside the pollen season. It is of interest
that FEV1 values during the season did not change
significantly with respect to outside the season [FEV1% of
predicted, from 105?3 (15) outside to 102?1 (17) during the
pollen season].
Changes in methacholine responsiveness was related to
the pattern of airway response to allergen outside the pollen
season: in the seven subjects with dual asthmatic response
(DAR) the responsiveness to methacholine significantly
increased from outside to during the pollen season
[methacholine PD20FEV1: from 0?58 (0?28) to 0?29
(0?40)mg respectively; P=0?021], while in the eight
subjects with EAR the responsiveness to methacholine did
not significantly increase from outside to during the pollen
season [methacholine PD20FEV1: from 1?27 (0?36) outside
to 0?79 (0?39) mg respectively; P=0?18].
The airway response to allergen showed significant
changes between outside and during the pollen season.
Allergen TD [0.33 (0?35) outside and 0.14 (0?33) during the
pollen season, P=0?02] and allergen PD20FEV1 signifi-
cantly decreased during the pollen season [0?23 (0?35)
outside and 0.10 (0?38) during the pollen season, P=0?04]
(Fig. 2). The individual analysis showed that nine out of 15
subjects had a decrease  50% of the allergen PD20FEV1
from outside to during the pollen season. This statistical
difference was due to the seven patients with LAR outside
the pollen season [PD20FEV1, from 0?25 outside to 0?08during the pollen season, P=5 0?05). No change was
evident in the remaining eight patients with only EAR
(PD20FEV1, from 0?22 outside to 0?11 during the pollen
season).
On the contrary, LAR did not show significant change
either as maximum percentage fall of FEV1 (713+ 8%
outside and710+ 3% during the pollen season, P=NS),
and as AUC (187+ 30 outside and 193+ 32 during pollen
season, P=NS).
On the basis of the pattern of response to sBPT outside
the pollen season, the subjects can be separated into three
groups: (i) seven subjects with isolated EAR; (ii) five
patients with a slight LAR (fall of FEV1 between 715%
and720%); (iii) three subjects with a consistent LAR (fall
of FEV1 4 20%).
From outside to during the pollen season the first group
showed a similar pattern of airway response to sBPT: five
out of seven subjects maintained a EAR, and two showed a
slight LAR during season. In the third group of patients
two out of three maintained the LAR, and one changed to
EAR during season. However, the second group of subjects
showed a shift to an isolated EAR in four out of five
subjects and just one subject maintained the same pattern
during the pollen season.
A significant relationship was found between the changes
of methacholine hyperresponsiveness and the changes in the
pattern of response to sBPT from outside to during pollen
season (P=0?01).
FIG 2. Comparison of total dose (TD) and PD20FEV1 of
allergen inhaled during sBPT performed outside and
during pollen season in 15 asthmatic subjects (open
circles). Closed circles represent the geometric means
(* P50?05).
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Our study shows that airway sensitivity to inhaled allergen
increases during pollen season without changes in the
pattern of response.
A significant increase of non-specific bronchial respon-
siveness to methacholine during the pollen season occurred,
similarly to in other studies (6,7,17). Only 40% of the
examined subjects had a significant increase in bronchial
responsiveness to methacholine from outside to during the
grass pollen season. On the other hand, the increase in
methacholine responsiveness was greater in subjects who
showed DAR than isolated EAR outside the grass pollen
season. These results confirm a previous observation (6)
and are suggestive of a positive relationship between the
presence of LAR and a higher bronchial sensitivity to non-
specific stimuli after natural exposure to the allergen.
After a time period of natural exposure to a seasonal
allergen, hypersensitivity to the inhalation of the allergen
can occur, requiring less inhaled antigen to produce a
positive response during the challenge test. This ‘priming
effect’ of allergen in seasonal asthma was studied by several
investigators, who obtained conflicting results. One study
showed no effect on bronchial sensitivity to the allergen in
nine subjects with ragweed-induced asthma, by measuring
the EAR to the allergen outside and during the ragweed
pollen season (10). Kelly et al. (11) and Crimi et al. (9)
showed an increase of bronchial sensitivity to the allergen
after the pollen season with respect to sBPT performed
before the pollen season. Our results show that an increase
of bronchial sensitivity to the allergen, expressed as a
decreased allergen PD20FEV1, occurs during natural
exposure to the pollen with respect to sBPT performed
outside the grass pollen season. This increased sensitivity tothe allergen may be due to the increase in airway
inflammation induced by natural exposure to the allergen
and consequently an increased allergic sensitivity of the
airways. In fact, markers of activation of airway inflam-
matory cells increase in the serum (18,19) and in BAL fluid
(20) of asthmatic subjects during natural exposure to the
allergen. It is of interest that the differences in EAR outside
and during the pollen season are due to patients with LAR
outside the season and not to patients without LAR.
In our study, the pattern of specific airway response did
not significantly change from outside to during pollen
season, in contrast to the results obtained by Crimi et al.
(9), who showed an increase in severity of LAR in sBPT
performed after the birch pollen season. A possible
difference is that in our study patients performed evalua-
tions during the pollen season, while in the study by Crimi
patients could be studied at the end of the season, after a
longer exposure time. It is problematic that drugs that some
patients used during the pollen season could influence
bronchial reactivity. In fact, inhaled low-dose beclometha-
sone and cromons need many weeks and continuous
treatment to change bronchial reactivity (21). Furthermore,
anti-histamines as cetirizine have no effect on EAR and
LAR (22).
The clinical significance of the different pattern of
response to sBPT in the laboratory is not known. Because
LAR is associated with an increase in non-specific
bronchial hyperresponsiveness (17) and with recruitment
of inflammatory cells in the airway (23), it is considered to
be a better reminiscent of spontaneous asthma than EAR,
and it is believed to be suggestive of a greater severity of
asthma. However, the relationship between LAR induced
in the laboratory and the outcome of spontaneous asthma
has not been proven yet, and no relevant difference could be
observed between subjects with isolated EAR and subjects
with DAR regarding the severity of symptoms, bronchial
responsiveness and response to the treatment (24,25). If
airway inflammation increases during natural exposure to
the allergen, LAR severity could increase during the pollen
season in allergic asthmatics. Our data did not support this
hypothesis, because LAR occurrence and severity (as
expressed by the maximal percentage fall in FEV1 between
the third and the seventh hour and by AUC) did not change
significantly during the pollen season, and if the subjects
were exposed for a consistent period time to allergen, 7
weeks after the beginning of pollen season (range 4–10
weeks). Moreover, if the five subjects with slight LAR
(DFEV1% from 15 to 20%) were considered, we found that
LAR was not present during the grass pollen season. In
these subjects the reduction in the LAR severity could be
ascribed to the lower TD of allergen delivered in the airway
in sBPT during season. In the same subjects the occurrence
and severity of LAR is dose-dependent, as proven by some
authors who were able to induce an LAR in subjects with
isolated EAR by an increase in the TD of allergen after pre-
treatment with short-acting b2-agonists (26). It is of interest
that in our study patients with LAR outside the pollen
season have a significant decrease in PD20FEV1 during the
pollen season. This could influence the development of
subsequent LAR.
1078 F. L. DENTE ET AL.In conclusion, we have shown that in sensitized subjects
natural exposure to allergen induces a reduction in the
threshold of response to the inhaled allergen during sBPT,
probably due to increased non-specific bronchial hyper-
responsiveness and airway inflammation during the season.
The absence of an increase in LAR severity during the
season does not support the hypothesis that LAR is a
marker of a greater airway reaction to the inhaled allergen.
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